Method for detecting voxelwise changes in fluorodeoxyglucose-positron emission tomography brain images via background adjustment in cancer clinical trials.

Method for detecting voxelwise changes in fluorodeoxyglucose-positron emission tomography brain images via background adjustment in cancer clinical trials.
复制标题

在癌症临床试验中通过背景调整检测氟脱氧葡萄糖-正电子发射断层扫描脑图像体素变化的方法。

DOI:
10.1117/1.jmi.4.2.024006
复制
发表时间:
2017
期刊:
Journal of medical imaging (Bellingham, Wash.)
影响因子:
--
通讯作者:
Yap,JeffreyT
Yap,JeffreyT
中科院分区:
--
文献类型:
--
作者:
Qin,Lei;Schwartzman,Armin;McCall,Keisha;Kachouie,NezamoddinN;Yap,JeffreyT

文献摘要

相似文献

An important challenge to using fluorodeoxyglucose-positron emission tomography (FDG-PET) in clinical trials of brain tumor patients is to identify malignant regions whose metabolic activity shows significant changes between pretreatment and a posttreatment scans in the presence of high normal brain background metabolism. This paper describes a semiautomated processing and analysis pipeline that is able to detect such changes objectively with a given false detection rate. Image registration and voxelwise comparison of the pre- and posttreatment images were performed. A key step is adjustment of the observed difference by the estimated background change at each voxel, thereby overcoming the confounding effect of spatially heterogeneous metabolic activity in the brain. Components of the proposed method were validated via phantom experiments and computer simulations. It achieves a false response volume accuracy of 0.4% at a significance threshold of 3 standard deviations. It is shown that the proposed methodology can detect lesion response with 100% accuracy with a tumor-to-background-ratio as low as 1.5, and it is not affected by the background brain glucose metabolism change. We also applied the method to FDG-PET patient images from a clinical trial to assess treatment effects of lapatinib, which demonstrated significant changes in metabolism corresponding to tumor regions.